Michelson Georg, Wärntges Simone, Harazny Joana, Oehmer Sebastian, Delles Christian, Schmieder Roland E
Augenklinik mit Poliklinik, Universität Erlangen-Nürnberg, Schwabachanlage 6, D-91053 Erlangen, Germany.
Retina. 2006 Apr;26(4):437-44. doi: 10.1097/01.iae.0000238550.74626.e5.
Arterial hypertension is involved in the pathogenesis of end organ damage by influencing the ability of the vascular endothelium to produce nitric oxide (NO). This study analyzes changes of retinal and systemic NO-dependent circulation parameters by inhibiting nitric oxide synthase (NOS) in both hypertensive and normotensive individuals.
In a double-blind crossover trial, 19 hypertensive patients (H, age 28.2 +/- 0.9 years) and 19 normotensive controls (N, age 26.9 +/- 0.9 years) were randomized treated either with candesartan or placebo. Both retinal capillary flow (RCF) and mean blood flow velocity of the central retinal artery (VCRA) were registered before and after NOS inhibition with N-monomethyl-L-arginine (L-NMMA, 3 mg/kg). In a subpopulation mean arterial pressure (MAP), cardiac output (CO), and the total peripheral resistance (TPR) were determined simultaneously.
Changes from baseline: In normotensive and hypertensive subjects infusion of L-NMMA led to an increase of MAP (N, +13.3 +/- 1.8%, P < 0.01; H, +14.3 +/- 2.4%, P < 0.01) and TPR (N, +36.9 +/- 3.8%, P < 0.01; H, +45.0 +/- 4.5%, P < 0.01), and to a decrease of CO (N, -21.1 +/- 1.5%, P < 0.01; H, -24.6 +/- 2.3%, P < 0.01). The L-NMMA effect on VCRA and RCF differed between controls and hypertensives. VCRA changed by + 17.3 +/- 6.2% (P < 0.05) and RCF by -7.3 +/- 3.0% (P < 0.05) in controls. In hypertensive subjects corresponding results were + 9.5 +/- 5.2% (P = NS) and + 2.7 +/- 3.8% (P = NS), respectively. The decrease of RCF due to L-NMMA was reduced in hypertension as compared to controls (P < 0.05). The calculated cross-sectional area of CRA was reduced by -58.7% in controls and increased by + 31.1% in hypertensive subjects. There was no significant correlation between the flow in the systemic and retinal circulation.
Only normotensives L-NMMA induces an acceleration of VCRA due to a probable vasoconstriction of the central retinal artery and despite of a reduced RCF. Already in early hypertension the NOS-dependent vascular tone in retinal arteries and capillaries is impaired. The regulation of the retinal capillary flow appeared to be independent from systemic circulation.
动脉高血压通过影响血管内皮产生一氧化氮(NO)的能力,参与终末器官损伤的发病机制。本研究通过抑制高血压和正常血压个体的一氧化氮合酶(NOS),分析视网膜和全身NO依赖循环参数的变化。
在一项双盲交叉试验中,19例高血压患者(H组,年龄28.2±0.9岁)和19例正常血压对照者(N组,年龄26.9±0.9岁)被随机分为接受坎地沙坦或安慰剂治疗。在用N-单甲基-L-精氨酸(L-NMMA,3mg/kg)抑制NOS之前和之后,记录视网膜毛细血管血流(RCF)和视网膜中央动脉平均血流速度(VCRA)。在一个亚组中,同时测定平均动脉压(MAP)、心输出量(CO)和总外周阻力(TPR)。
与基线相比的变化:在正常血压和高血压受试者中,输注L-NMMA导致MAP升高(N组,+13.3±1.8%,P<0.01;H组,+14.3±2.4%,P<0.01)和TPR升高(N组,+36.9±3.8%,P<0.01;H组,+45.0±4.5%,P<0.01),以及CO降低(N组,-21.1±1.5%,P<0.01;H组,-24.6±2.3%,P<0.01)。L-NMMA对VCRA和RCF的影响在对照组和高血压组之间有所不同。对照组中VCRA变化了+17.3±6.2%(P<0.05),RCF变化了-7.3±3.0%(P<0.05)。在高血压受试者中,相应结果分别为+9.5±5.2%(P=无统计学意义)和+2.7±3.8%(P=无统计学意义)。与对照组相比,高血压患者中L-NMMA导致的RCF降低幅度减小(P<0.05)。对照组中视网膜中央动脉(CRA)计算的横截面积减少了-58.7%,高血压受试者中增加了+31.1%。全身循环和视网膜循环中的血流之间无显著相关性。
仅在正常血压个体中,L-NMMA可能由于视网膜中央动脉的血管收缩,尽管RCF降低,但仍诱导VCRA加速。在早期高血压中,视网膜动脉和毛细血管中依赖NOS的血管张力就已受损。视网膜毛细血管血流的调节似乎独立于全身循环。